Recent market coverage
Next catalyst APPOS Austin
Markets command center
Pricing, HTA, manufacturing, deals, and congress catalysts — with equal prominence for FDA, EMA, and APAC regulators.
NovaPharmaNews Global Markets is a command center for pharmaceutical market intelligence across the United States (FDA), Europe (EMA), and Asia-Pacific (NMPA/PMDA). Browse market access and HTA coverage, manufacturing and supply signals, M&A and licensing activity, supplier partners, regional news, and upcoming congress catalysts — with equal prominence for each region.
Global pharma pulse
Aggregated from live regulatory feedsEqual prominence across FDA, EMA, and APAC — live 7-day signals, editorial picks, and spoke links per market.
Recent market coverage
Next catalyst APPOS Austin
Recent market coverage
Next catalyst Pharmaceutical Sciences and Innovations in Pharma Industry
Cross-cutting themes — jump into the regional category hub that matches your launch, access, or supply question.
12 live congresses · 6 in 14 days · 14 major events in 60 days
Next: APPOS Austin
Next: Pharmaceutical Sciences and Innovations in Pharma Industry
Next: BIO Asia-Taiwan 2026
Drugs, companies, pipeline, patents, trials, and events linked from market coverage.
It is a cross-region overview linking to US, European, and APAC market intelligence — including market access, pricing and HTA decisions, manufacturing, deals, supplier directories, and event calendars. Regional home pages (/us, /eu, /apac) remain canonical for day-to-day news.
Regulatory coverage tracks agency actions (FDA, EMA, NMPA approvals and guidance). Market access and pricing covers reimbursement, HTA decisions, launch strategy, and payer dynamics — surfaced under each region’s healthcare-access category.
Americas (US) focuses on FDA; Europe on EMA and related HTA bodies; Asia-Pacific on NMPA, PMDA, and regional APAC regulators. Each region card links to its regulator-aligned news and category hubs.
Editorial coverage combines FDA openFDA, EMA public updates, ClinicalTrials.gov, SEC EDGAR, congress calendars, and NovaPharmaNews analyst reporting. See our data sources policy for attribution and refresh cadence.